BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 29, 2005
View Archived Issues
MJL-1-109-2 demonstrates the involvement of CRF system in heroin dependence
Read More
Axcan reviews progress of fourth quarter
Read More
YN-968D1: A novel antiangiogenic agent
Read More
Roche describes novel, dual acting mitosis and angiogenesis inhibitor
Read More
In vivo results of APH-070 warrant its clinical evaluation
Read More
Ipsen to promote Pfizer's Artotec in France
Read More
Medivir and Jiangsu Hengrui Medicine Company extend COPD collaboration
Read More
Phase III PolyHeme trial recommended to continue
Read More
NicOx plans phase III program for HCT-3012 for osteoarthritis
Read More
Clinical results for Diamyd due in August 2006
Read More
Bosentan studies in pulmonary fibrosis show no effect on primary exercise endpoint
Read More
Varenicline, an effective and safe treatment for smoking cessation
Read More
MM-093 active, well tolerated in rheumatoid arthritis patients
Read More
Denosumab offers long-term bone improvements in postmenopausal women
Read More
EMD-336340 lowers plasma uric acid in healthy volunteers
Read More
C5a receptor antagonist ineffective in rheumatoid arthritis
Read More
Novel and potent inhibitor of c-Kit tyrosine kinase from Exelixis
Read More
Results from the ANTHEM-TIMI 32 trial of rNAPc2 presented
Read More
Hycamtin recommended for approval in Europe for relapsed SCLC
Read More
Duodopa completes market authorization in 28 European countries
Read More
Metvix approved for Bowen's disease in Europe
Read More
Results of natalizumab trials in Crohn's disease reported
Read More
U.K. approval for MT-100 for migraine
Read More
Recent patents disclose novel antiinfective agents
Read More
Steroid 5alpha-reductase inhibitors for BPH from Schering AG
Read More